Trojan picks up good vibrations
PRINCETON, N.J. Condom producer Trojan is launching a new line of vibrators, the company said Tuesday.
Trojan announced the introduction of Trojan Vibrations, which it described as powerful but with soft textures. The first, Vibrating Tri-Phoria, will become available in retail pharmacies and mass merchandisers in 2011.
“We’ve built a better vibrator for women and men to enjoy,” Trojan VP marketing Jim Daniels said. “We did our homework, and we listened to our consumers. We know that women and men want trusted and reliable pleasure products, and our world-class [research and development] team responded with a pioneering line of vibrators that will keep up the pleasure quotient during sex, and add some adventure and fun to America’s bedrooms.”
Now available at Rite Aid: Pertussis immunizations
CAMP HILL, Pa. One week after Walgreens announced that it was offering pertussis immunizations at its California locations, Rite Aid has followed suit.
Rite Aid said Monday that pharmacists at more than 500 Rite Aid stores across the state will offer pertussis, or whooping cough, vaccinations to individuals ages 7 years and older. The disease already has claimed the lives of nine infants in the state and is on pace to become the worst epidemic the state has seen in 50 years.
Patients in California and across the nation can go online to RiteAid.com/pharmacy/immunization/ to locate the most convenient Rite Aid pharmacy where immunizations are available. Patients are urged to call first to check availability and for questions on health insurance, which may cover some of the cost of a vaccination. Walk-ins are accepted whenever possible.
Rite Aid has been offering Tdap, the whooping cough vaccination, for the past several years, and currently is available in more than half of the states where Rite Aid operates, a Rite Aid spokesperson said.
"Helping protect against whooping cough in California is just another example of how convenient neighborhood Rite Aid pharmacists can help the community stay healthy," said Robert Thompson, Rite Aid EVP pharmacy. "Administering these shots is part of Rite Aid’s expanded national immunization program, with more than 7,000 pharmacists in more than 3,000 stores vaccinating patients against flu, pneumonia and up to a dozen other highly infectious diseases."
Walgreens announced earlier this month that it was offering vaccinations for pertussis at 150 select stores in the state.
Industry voices concern over Matrixx Initiatives AER case
WASHINGTON —The pharmaceutical industry earlier this month weighed in on the case “Matrixx Initiatives vs. James Siracusano and NECA-IBEW Pension Fund.”
Both the Consumer Healthcare Products Association and the Council for Responsible Nutrition, and separately the Natural Products Association, filed supporting briefs to the U.S. Supreme Court arguing that the mere nondisclosure of adverse event reports to shareholders should not give rise to liability under federal securities laws without applying a statistical significance standard. The Supreme Court had agreed to place the case on its docket in June.
“The statistical significance standard recognized by most courts of appeals appropriately recognizes that adverse event reports, standing alone, are not ‘material’ for purposes of federal securities laws,” CHPA and CRN wrote in its amicus curiae. “The statistical significance standard addresses the quality of the evidence of a relationship between an adverse event and a product, and therefore it is not the kind of ‘bright-line’ rule that [the Supreme] Court rejected in Basic Inc. vs. Levinson, 485 U.S. 224 (1988).”
“The practical consequence of the Ninth Circuit’s decision, if it is not reversed, is that manufacturers…very likely will be forced to disclose all AERs, however insignificant, in order to avoid meritless—but expensive—strike suits against the supplement industry,” said Jonathan Cohn, who authored the NPA’s separate amicus curiae.
“Companies cannot possibly guess in advance what will be deemed adequate disclosure years later in collateral litigation,” said Scott Bass, a partner at Sidley Austin, which is counsel for the NPA. “The [Dietary Supplement and Nonprescription Drug Consumer Protection Act] explicitly states that AERs are not proof of causation.”